doiSerbia

Cardiovascular diabetic autonomic neuropathy as a risk factor for electrical complications in acute myocardial ischemia

Vujošević Snežana (University of Montenegro, Faculty of Medicine, Clinical Center of Montenegro, Department of Endocrinology, Internal Medicine Clinic, Podgorica, Montenegro)
Radojević Nemanja (University of Montenegro, Faculty of Medicine, Clinical Center of Montenegro, Center for Pathology and Forensic Medicine, Podgorica, Montenegro)
Belada Nataša (Private Specialist Internal Medicine Clinic ’Cardio Lab’, Podgorica, Montenegro)
Mijajlović Nevena (University of Montenegro, Faculty of Mathematics and Natural Sciences, Podgorica, Montenegro)
Kalinić Valentina (Hospital "Blazo Orlandic", Department of Internal Medicine, Bar, Montenegro)
Borozan Sanja (University of Montenegro, Faculty of Medicine, Clinical Center of Montenegro, Department of Endocrinology, Internal Medicine Clinic, Podgorica, Montenegro)
Medenica Sanja (University of Montenegro, Faculty of Medicine, Clinical Center of Montenegro, Department of Endocrinology, Internal Medicine Clinic, Podgorica, Montenegro)

Introduction/Objective. Cardiovascular diabetic autonomic neuropathy (CDAN) mainly affects heart rhythm through sympathovagal imbalance. The objective of the study is to determine CDAN risk potential regarding electrical complications of acute myocardial ischemia (AMI), including admission glucose profile levels (AGP). Methods. Seventy-six patients suffering from type 2 diabetes mellitus were divided into two age-matched groups related to the presence of CDAN, and the influence of AGP on electrical complications was estimated. Ewing’s tests were used for diagnosis of CDAN. Results. Patients without CDAN have 42.86% risk for developing electrical complication into early post-AMI period. If it is a pre-existing condition, the risk is 63.64%, which is obvious, but not statistically significant. Considering the AGP, levels above 12.25 mmol/L as predictive for post-AMI electrical complications, in CDAN-positive patients with AGP levels above that cut-off value, the risk for electrical complications is raising up to 73.68%. The patients with CDAN who have AGP levels above the cut-off value have statistically higher risk for development electrical complications than those with lower levels (Z = 2.58, p < 0.01). On the other side, those without CDAN and with level of AGP lower than 12.25 mmol/L, the risk for electrical complications developing is as low as 23.08%. Conclusion. CDAN may be an important independent risk factor for electrical complications in postmyocardial ischemia period.

Keywords: cardiovascular autonomic neuropathy, admission glucose profile, diabetes mellitus, myocardial ischemia